Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of rps7 and srp14 genes in the treatment of renal insufficiency or renal injury

A technology of gene and gene suppression, applied in the field of application in the treatment of renal insufficiency or renal injury, can solve the problems such as apoptosis of renal tubular epithelial cells that have not yet been found

Active Publication Date: 2022-05-03
SICHUAN PROVINCIAL PEOPLES HOSPITAL
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although significant progress has been made in the study of renal tubular epithelial cell apoptosis in AKI, combined therapy targeting multiple cell death pathways can provide the greatest benefit in the treatment of AKI, but an effective and specific method to prevent and treat renal tubular epithelial cell death has not yet been found. apoptosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of rps7 and srp14 genes in the treatment of renal insufficiency or renal injury
  • Application of rps7 and srp14 genes in the treatment of renal insufficiency or renal injury
  • Application of rps7 and srp14 genes in the treatment of renal insufficiency or renal injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] SRP14 siRNA and RPS7 siRNA were used to knock down the expression of SRP14 or RPS7 in HK2 human renal tubular epithelial cells, respectively.

[0032] 1 Transfection of SRP14 siRNA

[0033] The concentration of SRP14 siRNA gene silencing was diluted to 5 nmol / ml according to the instructions (purchased from Thermo Fisher Company, #AM16708, AssayID#12804, RefSeq: NM_001309434.1).

[0034] 1) Dissolve 40pmol "SRP14 siRNA" in a 1.5ml EP tube containing 100μl Opti-DMEM-F12 serum-free and double-antibody-free medium, and mix gently.

[0035] 2) Dissolve 7.5 μl Lipo2000 in a 1.5ml EP tube containing 100 μl Opti-DMEM-F12 serum-free and double-antibody-free medium, mix well and place at room temperature for 5 minutes.

[0036] 3) Add the solution in 1) to the solution in 2), mix well and let stand for 15 minutes.

[0037] 4) When it is almost 13 minutes, remove the medium in the 6-well plate, wash the cells once with Opti-DMEM-F12 serum-free and double-antibody-free medium, a...

Embodiment 2

[0073] The cell treatment conditions of previous modeling were the same as in Example 1. The cell viability was measured by Japan Toren Cell Counting Kit-8 (CCK8, Cat. No. CK04) kit, the main component of CCK8 It can be reduced to water-soluble orange-yellow formazan by intracellular dehydrogenase, and the amount of formazan produced is proportional to the number of cells, which can indirectly measure the number of living cells.

[0074] see results figure 2 : In the normal negative control siRNA group (Silencer TM In Negative Control No.1siRNA (#AM4611, no significant similarity with mouse, rat or human gene sequence, that is, no interference, Thermo fisher, USA), the survival rate of cells after hypoxia and reoxygenation is significantly reduced (ctrl in the figure) , Knockdown of gene expression by SRP14 siRNA or RPS7 siRNA can significantly increase the survival rate of HK2 human renal tubular epithelial cells (IRI in the figure) after hypoxia-reoxygenation.

Embodiment 3

[0076] The cell treatment conditions of previous modeling were the same as in Example 1.

[0077] Detection of PI / Annexin V staining by flow cytometry

[0078] 1) Cell collection: Adherent HK2 cells were digested with trypsin and collected directly into a 5ml centrifuge tube. The number of cells per sample was (1-5)×10 6 / mL, centrifuge at 2500r / min for 5min, and discard the culture medium.

[0079] 2) Wash twice with pre-cooled PBS, and centrifuge at 2500r / min for 5min.

[0080] 3) Resuspend cells with 100ul of Binding Buffer, set blank control, single stain with PI, single stain with AnnexinV, double stain with experimental group, and incubate at room temperature in the dark for 10-15min.

[0081] 4) Flow cytometry analysis results

[0082] 5) Judgment of results: Apoptotic cells are resistant to all dyes used for cell viability identification, such as PI, but necrotic cells are not. The DNA of cells with damaged cell membranes can be stained with PI to produce red fluor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the application of RPS7 and SRP14 genes in the treatment of renal insufficiency or renal injury, and relates to the technical field of gene therapy. The invention discloses the application of an inhibitor for inhibiting gene expression in the preparation of drugs for treating renal insufficiency or renal injury. The research of the present invention finds for the first time that inhibiting the expression of RPS7 gene or SRP14 gene can treat renal insufficiency or renal insufficiency. Injury diseases, the present invention provides a new idea and strategy for treating renal insufficiency or renal injury diseases.

Description

technical field [0001] The invention relates to the technical field of gene therapy, in particular to the application of RPS7 and SRP14 genes in the treatment of renal insufficiency or renal injury. Background technique [0002] Renal insufficiency or renal injury (acute kidney injury, AKI) can easily progress to chronic kidney disease (chronic kidney disease, CKD) and end stage renal disease (end stage renal disease, ESRD), renal ischemia reperfusion injury (renal ischemia reperfusion) Injury (renal IRI) is an important cause of AKI and one of the main factors affecting the early functional recovery and long-term survival of the transplanted kidney after renal transplantation. [0003] Acute kidney injury (AKI) can easily progress to chronic kidney disease (CKD), leading to chronic renal insufficiency and end-stage renal disease (ESRD). The fatality rate continues to increase, causing great harm to families and society. Although the morbidity and mortality of AKI patients...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/00A61K31/7105A61P13/12
CPCA61K45/00A61K31/7105A61P13/12
Inventor 李怡
Owner SICHUAN PROVINCIAL PEOPLES HOSPITAL